Skip to Content
Contact Form Map & Directions Videos

Category: Product Defect

Oh, My Aching Eyes — Cooper Vision Lenses

11/17/2011
Blog
BY

Just how much are consumers of eye care products supposed to take before they have had enough? On the heels of two major disasters in the eye care industry yet another has emerged. Cooper Vision a major manufacturer of eye care products including soft contact lenses has announced the recall […]

Read More

Physician: First Do No Harm..Profit is Secondary?

10/25/2011
Blog
BY

“Quid pro quo” happens in business all the time. You scratch my back, I’ll scratch yours. Usually, the exchange is relatively even and the result doesn’t really cause any harm to anyone… or at least any harm of real consequence. But, give me a million dollars for my “quo” and […]

Read More

The FDA and the Saga of Multaq — When is enough, enough?

10/24/2011
Blog
BY

There are growing safety concerns over the anti-arrhythmia drug Multaq, (dronedarone), which is manufactured and marketed by Sanofi-Aventis and has generated a great deal of controversy and concern in just a few short years. Multaq was first approved by the Food & Drug Administration (“FDA”) in 2009 for use as […]

Read More

Smart Moms: Exercise Caution in Using Zoloft

10/4/2011
Blog
BY

Many physical, social, and chemical changes happen to a woman both before and after her pregnancy.  These changes can lead to women suffering from a number of symptoms including depression.  In fact, it has been said that one out of every five women has symptoms of depression during their pregnancy. […]

Read More

Better Health Through Shoes and Drugs

09/29/2011
Blog
BY

Wow, the federal regulatory agency, Federal trade Commission (FTC), has taken a firm stand on products that promise “a better way to a better butt”. The FTC has reached a settlement with shoemaker, Reebok, over its claims concerning the popular EasyTone shoes. I must confess that until reading the article […]

Read More

Dangerous Drugs — Why can’t testing be done BEFORE profits?

09/27/2011
Blog
BY

Your blood needs to clot, but it is a delicate balance. Insufficient clotting leads to excessive bleeding and too much clotting leads to obstructed blood flow, pulmonary embolism and strokes. So, it is understandable that the Food & Drug Administration became worried about reports that birth control medications containing drospirenone […]

Read More

Another Report About Metal on Metal Joint Implant Failure

09/19/2011
Blog
BY

The evidence condemning Metal on Metal (MOM) implants continues to grow. In a recent announcement by the National Joint Registry for England and Wales (NJR), it was revealed that 30% of MOM implants manufactured by DePuy Orthopaedics, Inc., a division of Johnson & Johnson require removal and revision within six […]

Read More

Bisphosphonate Drugs Require Vigilant, Educated Patients

09/12/2011
Blog
BY

If you are a user of bisphosphonate drugs – be a very active participant in your therapy; do periodic research; ask questions; and demand reasonable answers. An advisory panel to the Food & Drug Administration has recently taken action on the danger presented by drugs such as: Actonel, Fosamax and […]

Read More

Hear What Our Clients Have To Say

"Every question that I had was answered in mere minutes and the follow through that the staff, secretaries and attorneys had was superior. I have dealt with many, many firms that have all disappointed me and Searcy Denney was by far the most thorough - I highly recommend them!"
Posted By: Susan Baker